"Ample corporate cash, the need to continue to invest to address medium-term pipeline gaps and the resetting of biotech valuations will provide the backdrop for an active year."
— Roel van den Akker, PwC

“Pharma and biotech companies will likely look to trim operating expenses and focus on assets certain to be differentiators."
— BMO Capital Markets

“Scale is important in the healthcare industry, and for that reason we favor owning the largest names in the category. In addition, we expect continued market volatility next year, which favors a covered call strategy."
— Raj Lala, Evolve Funds

Who We Are

The Investing News Network is a growing network of authoritative publications delivering independent,
unbiased news and education for investors. We deliver knowledgeable, carefully curated coverage of a variety
of markets including gold, cannabis, biotech and many others. This means you read nothing but the best from
the entire world of investing advice, and never have to waste your valuable time doing hours, days or weeks
of research yourself.

At the same time, not a single word of the content we choose for you is paid for by any company or
investment advisor: We choose our content based solely on its informational and educational value to you,
the investor.

So if you are looking for a way to diversify your portfolio amidst political and financial instability, this
is the place to start. Right now.